IP
The startup has developed a molecule delivery technology that creates pathways through tissue structures, enabling the effective transport of active ingredients to target cells. This technology enhances the absorption of compounds typically administered through the skin, eyes, and mucous membranes, improving therapeutic outcomes for patients.
Updated 3 months ago
Funding
$7.5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a molecule delivery technology that creates pathways through tissue structures, enabling the effective transport of active ingredients to target cells. This technology enhances the absorption of compounds typically administered through the skin, eyes, and mucous membranes, improving therapeutic outcomes for patients.